Copyright Reports & Markets. All rights reserved.

Global Therapeutic Peptide Market Research Report 2021

Request for Sample of this report
Buy now

1 Therapeutic Peptide Market Overview

  • 1.1 Product Overview and Scope of Therapeutic Peptide
  • 1.2 Therapeutic Peptide Segment by Type
    • 1.2.1 Global Therapeutic Peptide Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Oral
    • 1.2.3 Injection
    • 1.2.4 Other
  • 1.3 Therapeutic Peptide Segment by Application
    • 1.3.1 Global Therapeutic Peptide Sales Comparison by Application: (2021-2027)
    • 1.3.2 Cancer
    • 1.3.3 Metabolic Disorders
    • 1.3.4 Central Nervous System
    • 1.3.5 Other
  • 1.4 Global Therapeutic Peptide Market Size Estimates and Forecasts
    • 1.4.1 Global Therapeutic Peptide Revenue 2016-2027
    • 1.4.2 Global Therapeutic Peptide Sales 2016-2027
    • 1.4.3 Therapeutic Peptide Market Size by Region: 2016 Versus 2021 Versus 2027

2 Therapeutic Peptide Market Competition by Manufacturers

  • 2.1 Global Therapeutic Peptide Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Therapeutic Peptide Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Therapeutic Peptide Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Therapeutic Peptide Manufacturing Sites, Area Served, Product Type
  • 2.5 Therapeutic Peptide Market Competitive Situation and Trends
    • 2.5.1 Therapeutic Peptide Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Therapeutic Peptide Players Market Share by Revenue
    • 2.5.3 Global Therapeutic Peptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Therapeutic Peptide Retrospective Market Scenario by Region

  • 3.1 Global Therapeutic Peptide Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Therapeutic Peptide Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Therapeutic Peptide Market Facts & Figures by Country
    • 3.3.1 North America Therapeutic Peptide Sales by Country
    • 3.3.2 North America Therapeutic Peptide Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Therapeutic Peptide Market Facts & Figures by Country
    • 3.4.1 Europe Therapeutic Peptide Sales by Country
    • 3.4.2 Europe Therapeutic Peptide Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Therapeutic Peptide Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Therapeutic Peptide Sales by Region
    • 3.5.2 Asia Pacific Therapeutic Peptide Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Therapeutic Peptide Market Facts & Figures by Country
    • 3.6.1 Latin America Therapeutic Peptide Sales by Country
    • 3.6.2 Latin America Therapeutic Peptide Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Therapeutic Peptide Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Therapeutic Peptide Sales by Country
    • 3.7.2 Middle East and Africa Therapeutic Peptide Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Therapeutic Peptide Historic Market Analysis by Type

  • 4.1 Global Therapeutic Peptide Sales Market Share by Type (2016-2021)
  • 4.2 Global Therapeutic Peptide Revenue Market Share by Type (2016-2021)
  • 4.3 Global Therapeutic Peptide Price by Type (2016-2021)

5 Global Therapeutic Peptide Historic Market Analysis by Application

  • 5.1 Global Therapeutic Peptide Sales Market Share by Application (2016-2021)
  • 5.2 Global Therapeutic Peptide Revenue Market Share by Application (2016-2021)
  • 5.3 Global Therapeutic Peptide Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 AbbVie
    • 6.1.1 AbbVie Corporation Information
    • 6.1.2 AbbVie Description and Business Overview
    • 6.1.3 AbbVie Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 AbbVie Therapeutic Peptide Product Portfolio
    • 6.1.5 AbbVie Recent Developments/Updates
  • 6.2 AstraZeneca
    • 6.2.1 AstraZeneca Corporation Information
    • 6.2.2 AstraZeneca Description and Business Overview
    • 6.2.3 AstraZeneca Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 AstraZeneca Therapeutic Peptide Product Portfolio
    • 6.2.5 AstraZeneca Recent Developments/Updates
  • 6.3 Ipsen
    • 6.3.1 Ipsen Corporation Information
    • 6.3.2 Ipsen Description and Business Overview
    • 6.3.3 Ipsen Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Ipsen Therapeutic Peptide Product Portfolio
    • 6.3.5 Ipsen Recent Developments/Updates
  • 6.4 Eli Lilly
    • 6.4.1 Eli Lilly Corporation Information
    • 6.4.2 Eli Lilly Description and Business Overview
    • 6.4.3 Eli Lilly Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Eli Lilly Therapeutic Peptide Product Portfolio
    • 6.4.5 Eli Lilly Recent Developments/Updates
  • 6.5 Merck
    • 6.5.1 Merck Corporation Information
    • 6.5.2 Merck Description and Business Overview
    • 6.5.3 Merck Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Merck Therapeutic Peptide Product Portfolio
    • 6.5.5 Merck Recent Developments/Updates
  • 6.6 Novo Nordisk
    • 6.6.1 Novo Nordisk Corporation Information
    • 6.6.2 Novo Nordisk Description and Business Overview
    • 6.6.3 Novo Nordisk Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Novo Nordisk Therapeutic Peptide Product Portfolio
    • 6.6.5 Novo Nordisk Recent Developments/Updates
  • 6.7 Novartis
    • 6.6.1 Novartis Corporation Information
    • 6.6.2 Novartis Description and Business Overview
    • 6.6.3 Novartis Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Novartis Therapeutic Peptide Product Portfolio
    • 6.7.5 Novartis Recent Developments/Updates
  • 6.8 Johnson and Johnson
    • 6.8.1 Johnson and Johnson Corporation Information
    • 6.8.2 Johnson and Johnson Description and Business Overview
    • 6.8.3 Johnson and Johnson Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Johnson and Johnson Therapeutic Peptide Product Portfolio
    • 6.8.5 Johnson and Johnson Recent Developments/Updates
  • 6.9 Sanofi
    • 6.9.1 Sanofi Corporation Information
    • 6.9.2 Sanofi Description and Business Overview
    • 6.9.3 Sanofi Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Sanofi Therapeutic Peptide Product Portfolio
    • 6.9.5 Sanofi Recent Developments/Updates
  • 6.10 Teva
    • 6.10.1 Teva Corporation Information
    • 6.10.2 Teva Description and Business Overview
    • 6.10.3 Teva Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Teva Therapeutic Peptide Product Portfolio
    • 6.10.5 Teva Recent Developments/Updates
  • 6.11 Takeda
    • 6.11.1 Takeda Corporation Information
    • 6.11.2 Takeda Therapeutic Peptide Description and Business Overview
    • 6.11.3 Takeda Therapeutic Peptide Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Takeda Therapeutic Peptide Product Portfolio
    • 6.11.5 Takeda Recent Developments/Updates

7 Therapeutic Peptide Manufacturing Cost Analysis

  • 7.1 Therapeutic Peptide Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Therapeutic Peptide
  • 7.4 Therapeutic Peptide Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Therapeutic Peptide Distributors List
  • 8.3 Therapeutic Peptide Customers

9 Therapeutic Peptide Market Dynamics

  • 9.1 Therapeutic Peptide Industry Trends
  • 9.2 Therapeutic Peptide Growth Drivers
  • 9.3 Therapeutic Peptide Market Challenges
  • 9.4 Therapeutic Peptide Market Restraints

10 Global Market Forecast

  • 10.1 Therapeutic Peptide Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Therapeutic Peptide by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Therapeutic Peptide by Type (2022-2027)
  • 10.2 Therapeutic Peptide Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Therapeutic Peptide by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Therapeutic Peptide by Application (2022-2027)
  • 10.3 Therapeutic Peptide Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Therapeutic Peptide by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Therapeutic Peptide by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Oral
    Injection
    Other

    Segment by Application
    Cancer
    Metabolic Disorders
    Central Nervous System
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    AbbVie
    AstraZeneca
    Ipsen
    Eli Lilly
    Merck
    Novo Nordisk
    Novartis
    Johnson and Johnson
    Sanofi
    Teva
    Takeda

    Buy now